Advertisement

Archive

2011: 106/1 (July) pp. 1-184

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

23 articles
1.
Stabilisation of atherosclerotic plaques
Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology

S. Ylä-Herttuala (1), J. F. Bentzon (2), M. Daemen (3), E. Falk (2), H. M. Garcia-Garcia (4), J. Herrmann (5), I. Hoefer (6), J. W. Jukema (7), R. Krams (8), B. R. Kwak (9), N. Marx (10), M. Naruszewicz (11), A. Newby (12), G. Pasterkamp (6), P. W. J. C. Serruys (4), J. Waltenberger (13), C. Weber (14), L. Tokgözoglu (15)

(1) Chairman of the position paper task force, A.I.Virtanen Institute, University of Eastern Finland, Kuopio, Finland; (2) Aarhus University Hospital, Aarhus, Denmark; (3) Academic Medical Center, Amsterdam, The Netherlands; (4) Erasmus University, Rotterdam, The Netherlands; (5) Mayo Clinic College of Medicine, Rochester, USA; (6) University Medical Center Utrecht, Utrecht, The Netherlands; (7) Leiden University Medical Center, Leiden, The Netherlands; (8) Chairman of the Working Group of Atherosclerosis and Vascular Biology, Imperial College, London, UK; (9) University of Geneva, Geneva, Switzerland; (10) University Hospital Aachen, Aachen, Germany; (11) Medical University of Warsaw, Warsaw, Poland; (12) Bristol Heart Institute, Bristol, UK; (13) Westfälische Wilhelms Universität, University Hospital Münster, Münster, Germany; (14) Ludwig-Maximilians-University Munich, Munich, Germany; (15) Past Chairman of the Working Group of Atherosclerosis and Vascular Biology, Hacettepe University, Ankara, Turkey

Thromb Haemost 2011 106 1: 1-19

https://doi.org/10.1160/TH10-12-0784

[Summary] [Free PDF] [Export citation]
2.

A. Thomas (1, 2), S. Lenglet (3), P. Chaurand (4), J. Deglon (1, 2), P. Mangin (1), F. Mach (3), S. Steffens (3), J.-L. Wolfender (5), C. Staub (1, 2)

(1) Unit of Toxicology, CURML, Geneva University Hospitals, Geneva, Switzerland; (2) Swiss Center of Applied Human Toxicology, University of Geneva, Geneva, Switzerland; (3) Division of Cardiology, Department of Internal Medicine, University Hospital, Foundation for Medical Researches, Geneva, Switzerland; (4) Department of Chemistry, Université de Montréal, Montreal, Quebec, Canada; (5) School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland

Thromb Haemost 2011 106 1: 20-33

https://doi.org/10.1160/TH10-12-0812

[Summary] [Free PDF] [Export citation]
3.

I. M. Ogilvie (1), S. A. Welner (1), W. Cowell (2), G. Y. H. Lip (3)

(1) BioMedCom Consultants inc., Montréal, Canada; (2) Global Health Economics and Reimbursement, Bayer HealthCare, Uxbridge, UK; (3) University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK

Thromb Haemost 2011 106 1: 34-44

https://doi.org/10.1160/TH10-10-0674

[Summary] [Free PDF] [Export citation]
4.

M. H. Huo (1)

(1) Department of Orthopedic Surgery, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA

Thromb Haemost 2011 106 1: 45-57

https://doi.org/10.1160/TH10-10-0653

[Summary] [Free PDF] [Export citation]
5.

A. Casonato (1), S. Sponga (1), E. Pontara (1), M. G. Cattini (1), C. Basso (2), G. Thiene (2), G. Cella (1), V. Daidone (1), G. Gerosa (1), A. Pagnan (1)

(1) Department of Cardiologic, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy; (2) Department of Medical Diagnostic Sciences and Special Therapies, University of Padua Medical School, Padua, Italy

Thromb Haemost 2011 106 1: 58-66

https://doi.org/10.1160/TH10-10-0634

[Summary] [PDF] [Pay per view] [Export citation]
6.

A. Darlington (1), J. L. Ferreiro (1), M. Ueno (1), Y. Suzuki (1), B. Desai (1), P. Capranzano (1), D. Capodanno (1), A. Tello-Montoliu (1), T. A. Bass (1), N. S. Nahman (1), D. J. Angiolillo (1)

(1) University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA

Thromb Haemost 2011 106 1: 67-74

https://doi.org/10.1160/TH10-12-0785

[Summary] [PDF] [Pay per view] [Export citation]
7.

I. Gosk-Bierska (1, 2), R. D. McBane (1), Y. Wu (1), J. Mruk (3, 4), A. Tafur (1), T. McLeod (1), W. E. Wysokinski (1)

(1) Mayo Clinic and Foundation for Education and Research, Rochester, Minnesota, USA; (2) University Medical School of Wroclaw, Poland; (3) Department of Internal Medicine, University of Kansas School of Medicine-Wichita, Witchita, Kansas, USA; (4) Wichita Clinic, Wichita, Kansas, USA

Thromb Haemost 2011 106 1: 75-82

https://doi.org/10.1160/TH10-11-0765

[Summary] [PDF] [Pay per view] [Export citation]
8.

M. Gallerani (1), D. Imberti (1), W. Ageno (2), F. Dentali (2), R. Manfredini (3)

(1) Department of Internal Medicine, Hospital of Ferrara, Italy; (2) Department of Clinical Medicine, University of Insubria, Varese, Italy; (3) Department of Clinical and Experimental Medicine, Clinica Medica and Vascular Diseases Center, University of Ferrara, Italy

Thromb Haemost 2011 106 1: 83-89

https://doi.org/10.1160/TH11-02-0068

[Summary] [PDF] [Pay per view] [Export citation]
9.

N. Mishra (1), E. Vercauteren (1), J. Develter (1), R. Bammens (1), P. J. Declerck (1), A. Gils (1)

(1) Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Leuven, Belgium

Thromb Haemost 2011 106 1: 90-101

https://doi.org/10.1160/TH10-08-0546

[Summary] [PDF] [Pay per view] [Export citation]
10.

B. Zöller (1), X. Li (1), J. Sundquist (1, 2), K. Sundquist (1)

(1) Center for Primary Health Care Research, Lund University, Malmö, Sweden; (2) Stanford Prevention Research Centre, Stanford University School of Medicine, Palo Alto, California, USA

Thromb Haemost 2011 106 1: 102-112

https://doi.org/10.1160/TH10-10-0655

[Summary] [PDF] [Pay per view] [Export citation]
11.

P. L. Lutsey (1), M. Cushman (2), S. R. Heckbert (3), W. Tang (1), A. R. Folsom (1)

(1) Division of Epidemiology & Community Health, Univ. of Minnesota, Minneapolis, Minnesota, USA; (2) Departments of Medicine and Pathology, University of Vermont, Burlington, Vermont, USA; (3) Department of Epidemiology, University of Washington, Seattle, Washington, USA

Thromb Haemost 2011 106 1: 113-120

https://doi.org/10.1160/TH11-02-0100

[Summary] [PDF] [Pay per view] [Export citation]
12.

Online Supplementary Material

J.-L. Pellequer (1), S.-w. W. Chen (1), D. Saboulard (2), M. Delcourt (2), C. Négrier (3), J.-L. Plantier (3)

(1) CEA, iBEB, Service de Biochimie et Toxicologie Nucléaire, Bagnols sur Cèze, France; (2) Biométhodes, Evry, France; (3) Laboratoire d’hémobiologie EA4174-IFR62 Faculté de médecine RTH Laennec, Université de Lyon, Lyon, France

Thromb Haemost 2011 106 1: 121-131

https://doi.org/10.1160/TH10-09-0572

[Summary] [PDF] [Pay per view] [Export citation]
13.

N. Taglieri (1), F. Saia (1), C. Rapezzi (1), C. Marrozzini (1), M. L. Bacchi Reggiani (1), T. Palmerini (1), P. Ortolani (1), G. Melandri (1), S. Rosmini (1), L. Cinti (1), L. Alessi (1), F. Vagnarelli (1), C. Villani (1), A. Branzi (1), A. Marzocchi (1)

(1) Institute of Cardiology, St. Orsola/Malpighi Hospital, Bologna University, Bologna, Italy

Thromb Haemost 2011 106 1: 132-140

https://doi.org/10.1160/TH10-12-0821

[Summary] [PDF] [Pay per view] [Export citation]
14.

Online Supplementary Material

A. Schäfer (1), U. Flierl (1), J. Kössler (2), N. Seydelmann (3), A. Kobsar (2), S. Störk (3), J. Bauersachs (1)

(1) Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Germany; (2) Institut für Klinische Biochemie und Pathobiochemie, University Hospital Würzburg, Germany; (3) Medizinische Klinik und Poliklinik I and Comprehensive Heart Failure Center, University Hospital Würzburg, Germany

Thromb Haemost 2011 106 1: 141-148

https://doi.org/10.1160/TH11-01-0022

[Summary] [PDF] [Pay per view] [Export citation]
15.

M. P. P. van Herk-Sukel (1), S. Shantakumar (2), P. W. Kamphuisen (3), F. J. A. Penning-van Beest (1), R. M. C. Herings (1, 4)

(1) PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands; (2) GlaxoSmithKline, Oncology Biometrics and Epidemiology, Research & Development, RTP, North Carolina, USA; (3) Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands; (4) Department of Health Policy & Management, Erasmus University Medical Centre, Rotterdam, the Netherlands

Thromb Haemost 2011 106 1: 149-155

https://doi.org/10.1160/TH10-12-0778

[Summary] [PDF] [Pay per view] [Export citation]
16.

H. Mani (1), C. Hesse (1), G. Stratmann (1), E. Lindhoff-Last (1)

(1) Department of Internal Medicine, Division of Vascular Medicine, Johann Wolfgang Goethe-University Hospital Frankfurt/Main, Germany

Thromb Haemost 2011 106 1: 156-164

https://doi.org/10.1160/TH10-10-0667

[Summary] [PDF] [Pay per view] [Export citation]
17.

J. E. van Loon (1), P. P. T. de Jaegere (2), H. Ulrichts (3), H. H. D. M. van Vliet (1), M. P. M. de Maat (1), P. G. de Groot (4), M. L. Simoons (2), F. W. G. Leebeek (1)

(1) Department of Haematology, Erasmus Medical Center Rotterdam, the Netherlands; (2) Department of Cardiology, Erasmus Medical Center Rotterdam, the Netherlands; (3) IRC, Laboratory for Thrombosis Research, KU Leuven, Leuven, Belgium; (4) Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, the Netherlands

Thromb Haemost 2011 106 1: 165-171

https://doi.org/10.1160/TH10-12-0804

[Summary] [PDF] [Pay per view] [Export citation]
18.

A. G. Singh (1), I. S. Hamarneh (1), M. W. Karwal (1), S. R. Lentz (1)

(1) Department of Internal Medicine, The University of Iowa Carver College of Medicine, Iowa City, Iowa, USA

Thromb Haemost 2011 106 1: 172-174

https://doi.org/10.1160/TH11-02-0097

[Summary] [PDF] [Pay per view] [Export citation]
19.

Online Supplementary Material

J. A. Jakubowski (1), Y. G. Li (1), C. D. Payne (2), D. S. Small (1), K. J. Winters (1)

(1) Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA; (2) Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, UK

Thromb Haemost 2011 106 1: 174-176

https://doi.org/10.1160/TH10-11-0764

[Summary] [PDF] [Pay per view] [Export citation]
20.

M. Oudghiri (1), H. Keita (2, 3), E. Kouamou (1), M. Boutonnet (2), M. Orsini (4), C. Desconclois (5), L. Mandelbrot (6, 3), J.-P. Daures (4), A. Stépanian (1, 7), E. Peynaud-Debayle (1), D. de Prost (1, 3, 7)

(1) AP-HP, Service d’Hématologie Biologique, Hôpital Louis Mourier, Colombes, France; (2) AP-HP, Service d’Anesthésie, Hôpital Louis Mourier, Colombes, France; (3) Université Paris VII, Denis Diderot, Paris, France; (4) Institut Universitaire de Recherche Clinique, Laboratoire de Biostatistiques et d’Epidémiologie, Montpellier, France; (5) APHP, Service d’Hématologie Biologique, Hôpital Bicêtre; (6) AP-HP, Service de Gynécologie-Obstétrique, Hôpital Louis Mourier, Colombes, France; (7) INSERM U770, Hôpital Bicêtre, Le Kremlin-Bicêtre cedex, France

Thromb Haemost 2011 106 1: 176-178

https://doi.org/10.1160/TH11-02-0058

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-23